Phenylephrine is the main decongestant ingredient in soluble and tablet-form cold-and-flu medicines such as Lemsip, Beechams, ...

Entera Bio ( (ENTX) ) just unveiled an announcement. Entera Bio Ltd., a leader in oral peptide development, reported Q3 2024 financial results ...

JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today reported ...

LEMSIP and other popular cold and flu tablets should be pulled from Britain’s shelves because they don’t work, experts have ...

The FDA also held a meeting last year to study the “Generally Recognized as Safe and Effective” status of oral phenylephrine ...

The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold medications. Here's what you need to know.

It comes as US health officials yesterday proposed getting rid of oral drugs containing phenylephrine over concerns they are ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...

The FDA also held a meeting last year to study the “Generally Recognized as Safe and Effective” status of oral phenylephrine as a nasal decongestant, the release stated. The committee “unanimously ...

First randomized placebo-controlled trial in NTM abscessusSymptom-based endpoints showed favorable improvement in frequency and severity of the most common symptomsMicrobiologic endpoints showed ...

The injectables result in weight losses of about 10 to 15% in patients, Dr. Mohan says. “The daily oral tablet (Rybelsus), ...

The global oral solid dosage pharmaceutical formulation market is poised for remarkable expansion, with projections indicating a growth from USD 629,582.6 million in 2024 to USD 895,636.0 million by ...